Black Bird Biotech, Inc.
BBBT · OTC
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -21% | 81.3% | 224.1% | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | -$0 | $0 | $0 | -$0 |
| % Margin | -67.7% | 18.8% | 51% | -0.2% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $1 | $1 | $1 | $0 |
| SG&A Expenses | $1 | $1 | $1 | $0 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $1 | $1 | $1 | $0 |
| Operating Income | -$1 | -$1 | -$1 | -$0 |
| % Margin | -1,560.4% | -1,389.2% | -1,188.8% | -451.9% |
| Other Income/Exp. Net | -$0 | -$0 | -$0 | $0 |
| Pre-Tax Income | -$2 | -$2 | -$1 | -$0 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$2 | -$2 | -$1 | -$0 |
| % Margin | -2,009.1% | -1,734% | -1,200.6% | -920.8% |
| EPS | -0.005 | -0.009 | -0.006 | -0.001 |
| % Growth | 46.2% | -63.2% | -307.1% | – |
| EPS Diluted | -0.005 | -0.009 | -0.006 | -0.001 |
| Weighted Avg Shares Out | 331 | 194 | 120 | 120 |
| Weighted Avg Shares Out Dil | 331 | 194 | 120 | 120 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$1 | -$1 | -$1 | -$0 |
| % Margin | -1,452.5% | -1,355.9% | -1,187.9% | -823.7% |